These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12112158

  • 21. A kinetic-pharmacodynamic model for clinical trial simulation of antidepressant action: application to clomipramine-lithium interaction.
    Gruwez B, Poirier MF, Dauphin A, Olié JP, Tod M.
    Contemp Clin Trials; 2007 May; 28(3):276-87. PubMed ID: 17059901
    [Abstract] [Full Text] [Related]

  • 22. Relapse rates with long-term antidepressant drug therapy: a meta-analysis.
    Williams N, Simpson AN, Simpson K, Nahas Z.
    Hum Psychopharmacol; 2009 Jul; 24(5):401-8. PubMed ID: 19526453
    [Abstract] [Full Text] [Related]

  • 23. Antidepressant augmentation with lithium.
    Manning JS, Connor PD.
    J Fam Pract; 1994 Oct; 39(4):379-83. PubMed ID: 7931118
    [Abstract] [Full Text] [Related]

  • 24. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG, Peselow E, Mulcare L, Case BG, Fieve R.
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
    Inoue T, Nakagawa S, Kitaichi Y, Izumi T, Tanaka T, Masui T, Kusumi I, Denda K, Koyama T.
    J Affect Disord; 2006 Oct; 95(1-3):61-7. PubMed ID: 16797078
    [Abstract] [Full Text] [Related]

  • 26. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 27. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [Abstract] [Full Text] [Related]

  • 28. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Feb; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 29. Serotonin transporter gene and response to lithium augmentation in depression.
    Stamm TJ, Adli M, Kirchheiner J, Smolka MN, Kaiser R, Tremblay PB, Bauer M.
    Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
    [Abstract] [Full Text] [Related]

  • 30. Impact of study design on the results of continuation studies of antidepressants.
    Zimmerman M, Posternak MA, Ruggero CJ.
    J Clin Psychopharmacol; 2007 Apr; 27(2):177-81. PubMed ID: 17414242
    [Abstract] [Full Text] [Related]

  • 31. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J.
    JAMA; 2001 Mar 14; 285(10):1299-307. PubMed ID: 11255384
    [Abstract] [Full Text] [Related]

  • 32. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT, Frampton CM, Luty SE, Joyce PR.
    J Affect Disord; 2009 Apr 14; 114(1-3):263-70. PubMed ID: 18805590
    [Abstract] [Full Text] [Related]

  • 33. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov 14; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 34. [Maintenance treatment and relapse prophylaxis of depressive disorders].
    Nyhuis PW.
    MMW Fortschr Med; 2006 Jan 26; 148(4):26-8, 30. PubMed ID: 16502796
    [Abstract] [Full Text] [Related]

  • 35. [Therapy refractory depression].
    Hatzinger M, Holsboer-Trachsler E.
    Wien Med Wochenschr; 1999 Jan 26; 149(18):511-4. PubMed ID: 10637955
    [Abstract] [Full Text] [Related]

  • 36. Lithium potentiation of antidepressant treatment.
    Louie AK, Meltzer HY.
    J Clin Psychopharmacol; 1984 Dec 26; 4(6):316-21. PubMed ID: 6511998
    [Abstract] [Full Text] [Related]

  • 37. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    Tijdschr Psychiatr; 2006 Dec 26; 48(4):271-81. PubMed ID: 16955991
    [Abstract] [Full Text] [Related]

  • 38. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients.
    Austin LS, Arana GW, Melvin JA.
    J Clin Psychiatry; 1990 Aug 26; 51(8):344-5. PubMed ID: 2380160
    [Abstract] [Full Text] [Related]

  • 39. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD, Bodkin JA.
    J Clin Psychopharmacol; 2006 Dec 26; 26(6):579-86. PubMed ID: 17110814
    [Abstract] [Full Text] [Related]

  • 40. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov 26; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.